Based in San Diego, LJP is engaged in the research and development of therapeutics for the treatment of autoimmune, inflammatory and other diseases...One, exclusively licensed from the University of California at San Diego, is a program to develop inhibitors of the enzyme phospholipase A2 (PLA2) as potential treatments for inflammation and inflammatory diseases
The San Diego company is developing DNA-based diagnostic tests that use a combination of electronic microchip manipulation and biotechnology to detect a wide range of genetic and infectious diseases
Shareholders had accused the San Diego company of not disclosing in a timely manner the problems it was having with the FDA regarding approval of its PerioGard Tissue Monitor, a non-invasive procedure used to detect periodontal tissue disease
Shareholders had accused the San Diego company of not disclosing in a timely manner the problems it was having with the FDA regarding approval of its PerioGard Tissue Monitor, a non-invasive procedure used to detect periodontal tissue disease
Idec of San Diego will be reimbursed for its research expenses under the collaboration and will receive developmental milestone payments and royalties on sales of any products resulting from the partnership
In addition, Viagene of San Diego is currently conducting three RAC-approved Phase I safety trials with a gene transfer product for the treatment of HIV infection
market to control the lesser mealworm alone is more than $20 million per year, said Mike Sund, corporate communications director for Mycogen of San Diego
At the end of January, FDA told Telios of San Diego that it wanted information to show that a representative cross-section of the patient population with diabetic foot ulcers had been enrolled in the Argidene trial (see BioWorld, Jan. 26
The Bioplex Group Inc., which describes itself as a turnkey development, construction and finance company, announced Thursday that it has opened offices in San Diego and Wellesley, Mass
The technology, according to the privately held San Diego company, can be used to facilitate the humanization and optimization of monoclonal antibodies, as well as in the creation of peptide libraries and the optimization of peptides
other investors also provided seed funding for the San Diego company...Signal also has rights to a technology patented by Fred Gage, a professor in the department of neurosciences at the University of California, San Diego (UCSD), and a scientific founder of Signal
of San Diego named to its board of directors Blake Ingle, president and chief executive officer of Canji Inc...of San Diego has appointed Richard Kenley vice president of product development
Based in San Diego, LJP is engaged in the research and development of therapeutics for the treatment of autoimmune, inflammatory and other diseases...One, exclusively licensed from the University of California at San Diego, is a program to develop inhibitors of the enzyme phospholipase A2 (PLA2) as potential treatments for inflammation and inflammatory diseases